Endonovo Therapeutics, Inc. Stock Price - ENDV

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 0.05 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Endonovo Therapeutics, Inc. (QB) ENDV Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.0026 -4.68% 0.053 0.0556 0.0451 0.0547 0.0556 16:30:19
Bid Price Ask Price Spread Spread % News
0.0465 0.053 0.0065 12.26% - -
Stock Trades Traded Volume Average Volume 52 Week Range
83 1,040,411 2.91M 0.0092 - 0.27
Last Trade Time Type Quantity Stock Price Currency
16:00:10 formt 1,000 $0.05 USD

Endonovo Therapeutics, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 12.51M 236.11M $ -5.32M - -2.35 622.09k
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
289.32k 0.12% $ - 0.00% - -

more financials information »

Endonovo Therapeutics, Inc. (QB) News

Latest ENDV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENDV Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.0520.05580.0350.0000649k1M980k0.0011.92%
1 Month0.0660.09790.0350.0000341k3M998k-0.013-19.70%
3 Months0.044550.1360.0350.0000341k9M3M0.0084518.97%
6 Months0.0640.1360.00920.000023k25M3M-0.011-17.19%
1 Year0.17990.270.00920.000050025M2M-0.1269-70.54%
3 Years5.315.310.00920.0000025M588k-5.257-99.00%
5 Years0.515.310.00010.0000025M391k-0.457-89.61%

Endonovo Therapeutics, Inc. (QB) Description

Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. Endonovo's Immunotronics platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. Endonovo's Cytotronics platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.